<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the association between 11q23 abnormalities and the clinical, hematologic, prognostic aspects of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 6000 cases of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> from our hospital and near regions in China were investigated between October 1985 and November 1998 </plain></SENT>
<SENT sid="2" pm="."><plain>Chromosome preparations were made on bone marrow cells by using direct method and/or unstimulated short-term cultures </plain></SENT>
<SENT sid="3" pm="."><plain>Karyotypes were analyzed by R-banding technique and expressed according to ISCN(1995) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: 11q23 abnormalities were found in 28 of 6000 cases with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>(0.47%) </plain></SENT>
<SENT sid="5" pm="."><plain>It may be separated into seven cytonetic categories: t(4;11)(q21;q23)(ten cases), t(11;19)(q23;p13)(five cases), t(9;11)(p12;q23)(two cases), t(10;11)(p15;q23)(two cases), t(6;11)(q27;q23) (one case), del(11)(q23)(seven cases), and t(11;?)(q23;?)(one case) </plain></SENT>
<SENT sid="6" pm="."><plain>The diagnoses included <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> in 14 cases (M(2a), three; M(4), two; M(5a), one; M(5b), eight), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>(ALL) in 10 cases, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> in three cases and malignant <z:mpath ids='MPATH_146,MPATH_652'>histiocytosis</z:mpath> in one case </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 10 cases with t(4;11) anomaly were ALL </plain></SENT>
<SENT sid="8" pm="."><plain>Follow-up data were available for 22 of them </plain></SENT>
<SENT sid="9" pm="."><plain>Their median survival was 113 days </plain></SENT>
<SENT sid="10" pm="."><plain>The patients may be grouped according to the presence or absence of additional abnormalities and/or <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="11" pm="."><plain>The median survival was 75 days for five patients with 11q23 anomaly only, 18 days for two patients with 11q23 and additional abnormalities, 135 days for 10 patients with 11q23 anomaly, additional abnormalities and <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype, and 150 days for 5 patients with 11q23 anomaly and <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: 11q23 abnormalities were mainly seen in ALL and <z:hpo ids='HP_0004845'>acute monocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>Their prognosis was very poor </plain></SENT>
<SENT sid="14" pm="."><plain>Both additional abnormalities and lack of <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype had adverse effects on the survival of patients </plain></SENT>
<SENT sid="15" pm="."><plain>Thus, they represent a unique clinical-cytogenetic association </plain></SENT>
<SENT sid="16" pm="."><plain>11q23 abnormality; <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e>; <z:hpo ids='HP_0004845'>acute monocytic leukemia</z:hpo>; <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>; prognosis </plain></SENT>
</text></document>